Speaker: Jeremy M. Shefner, MD, PhD Professor of Neurology Barrow Neurological Institute Title: A Phase 2 Trial of Pridopidine in ALS, Studied as a Regimen With the Healey Platform Trial Date: Friday, April 11, 2025, 1:00-2:00 p.m. ET Please click the link below to join the webinar: https://duke.zoom.us/j/91651086721?pwd=7DftSd42zfX3A3gWZQh3rtinj5SSGr.1 Passcode: 800685 One-Tap Mobile +16469313860,,91651086721#,,,,*800685# US +13017158592,,91651086721#,,,,*800685# […]